Cost-effectiveness of programs to eliminate disparities in elderly vaccination rates in the United States

BMC Public Health

Table 5 Results of one-way sensitivity analyses

	Parameter values
Parameter	Base case	ICER > $50,000/QALY	ICER > $100,000/QALY
PPSV^a vaccination rate, very high intensity program (yr 10)	78.0%	<68.0%	n/a^b
Cost of very high intensity program (per elder per year)	$17.84	>$23.65	n/a^b
PPSV vaccination rate, high intensity program (yr 10)	63.0%	>71.7%	n/a^b
Influenza vaccination rate, very high intensity program (yr 10)	81.0%	<78.2%	<76.8%
Influenza vaccination rate, high intensity program (yr 10)	71.0%	>72.7%	>73.5%

^aPneumococcal polysaccharide vaccine.
^bMaximum variation in these parameters did not cause ICER of preferred program to cross $100,000/QALY threshold.
Results presented only for those parameters, ordered from most to least impact, causing the incremental cost-effectiveness ratio (ICER) of the very high intensity vaccination program to cross $50,000 and $100,000/QALY willingness-to-pay thresholds.

ISSN: 1471-2458